ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2022
[Efficacy and safety of Polatuzumab Vedotin in combination with rituximab plus bendamustine in patients with relapsed/refractory diffuse large B-cell lymphoma: a single center analysis].
F C Kong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.